Trial
NCT03982030
Dalbavancin Outpatient Pilot
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
—
Condition
Gram-Positive Bacterial Infections
Intervention
Dalbavancin
Why stopped
Lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-05-03